The European Investment Bank (EIB) and BioNTech (Nasdaq: BNTX, BioNTech) have concluded a €100 million debt financing agreement to support the development of BNT162, the company’s COVID-19 vaccine programme. The deal will also allow the company to expand its manufacturing capacity in order to supply the vaccine fast worldwide in response to the pandemic. This […]
Read More
Regulatory flexibility to ensure availability of veterinary medicines during COVID-19
The European Commission, EMA and the Coordination Group for Mutual Recognition and Decentralised Procedure – Veterinary (CMDv) have issued guidance on adaptations to the regulatory framework to companies that develop, manufacture and distribute veterinary medicines in order to address some of the constraints posed by the COVID-19 pandemic. According to the jointly developed question-and-answer (Q&A) document, regulatory rules […]
Read MoreCoronavirus Global Response: €7.4 billion raised for universal access to vaccines
The Commission has registered €7.4 billion, equivalent to $8 billion, in pledges from donors worldwide during the Coronavirus Global Response pledging event. This includes a pledge of €1.4 billion by the Commission. This almost reaches the initial target of €7.5 billion and is a solid starting point for the worldwide pledging marathon, which begins today. The […]
Read More